Biologicals and biosimilars

“The way is the product” – this was the core message of the presentation on “Biologicals & biosimilars – and the small difference…” held by Professor Hildegard Sourgens, MD, PhD, during a meeting of the German Society for Pharmaceutical Medicine (DGPharMed) on 13 April 2015 in Mannheim before a broad audience. The development and approval of these drugs is strictly regulated in order to be able to guarantee consistent quality, safety and effectiveness at all times.

One of our Project Coordinators attended and was able to gain further expertise by attending this interesting event.